Vernalis (Apokyn & Vernalis US Commercial Operations) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Vernalis (Apokyn & Vernalis US Commercial Operations) General Information

Description

Developer of pharmaceutical products headquartered in Wokingham, England. The company develops and applies fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives, inflammation and integrates fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive synthetic organic and medicinal chemistry expertise to enable drug discovery on both established and novel targets.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Oakdene Court, 613 Reading Road
  • Winnersh
  • Wokingham RG41 5UA
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Oakdene Court, 613 Reading Road
  • Winnersh
  • Wokingham RG41 5UA
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vernalis (Apokyn & Vernalis US Commercial Operations) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vernalis (Apokyn & Vernalis US Commercial Operations)‘s full profile, request access.

Request a free trial

Vernalis (Apokyn & Vernalis US Commercial Operations) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vernalis (Apokyn & Vernalis US Commercial Operations)‘s full profile, request access.

Request a free trial

Vernalis (Apokyn & Vernalis US Commercial Operations) FAQs

  • Where is Vernalis (Apokyn & Vernalis US Commercial Operations) headquartered?

    Vernalis (Apokyn & Vernalis US Commercial Operations) is headquartered in Wokingham, United Kingdom.

  • What industry is Vernalis (Apokyn & Vernalis US Commercial Operations) in?

    Vernalis (Apokyn & Vernalis US Commercial Operations)’s primary industry is Drug Discovery.

  • Is Vernalis (Apokyn & Vernalis US Commercial Operations) a private or public company?

    Vernalis (Apokyn & Vernalis US Commercial Operations) is a Private company.

  • What is the current valuation of Vernalis (Apokyn & Vernalis US Commercial Operations)?

    The current valuation of Vernalis (Apokyn & Vernalis US Commercial Operations) is .

  • What is Vernalis (Apokyn & Vernalis US Commercial Operations)’s current revenue?

    The current revenue for Vernalis (Apokyn & Vernalis US Commercial Operations) is .

  • Who are Vernalis (Apokyn & Vernalis US Commercial Operations)’s investors?

    Vernalis has invested in Vernalis (Apokyn & Vernalis US Commercial Operations).

  • When was Vernalis (Apokyn & Vernalis US Commercial Operations) acquired?

    Vernalis (Apokyn & Vernalis US Commercial Operations) was acquired on 01-Jul-2008.

  • Who acquired Vernalis (Apokyn & Vernalis US Commercial Operations)?

    Vernalis (Apokyn & Vernalis US Commercial Operations) was acquired by Ipsen (Pharmaceuticals).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »